生存率-话题@MedSci

#生存率#

482篇内容 | 3060人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256605, encodeId=3d27125660554, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Cardiovasc Ther：华法林对曲前列尼尔治疗的肺动脉高压患者生存率有影响吗？, objectType=article, longId=117414, objectId=ea5d11e4141d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea5d11e4141d, replyNumber=0, likeNumber=80, createdTime=2017-10-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea5d11e4141d, moduleTitle=Cardiovasc Ther：华法林对曲前列尼尔治疗的肺动脉高压患者生存率有影响吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea5d11e4141d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256604, encodeId=bb23125660477, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Obstet Gynecol：卵巢静脉血栓患者复发性静脉血栓栓塞的发生率和生存率如何？, objectType=article, longId=117159, objectId=b08211e15984, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b08211e15984, replyNumber=0, likeNumber=44, createdTime=2017-10-24, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b08211e15984, moduleTitle=Obstet Gynecol：卵巢静脉血栓患者复发性静脉血栓栓塞的发生率和生存率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b08211e15984)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256603, encodeId=db6912566037d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：经导管主动脉瓣植入后的相对生存率, objectType=article, longId=117076, objectId=bea711e076b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bea711e076b7, replyNumber=0, likeNumber=80, createdTime=2017-10-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bea711e076b7, moduleTitle=JAHA：经导管主动脉瓣植入后的相对生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bea711e076b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256602, encodeId=9578125660258, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Chest：患COPD肺移植候选人的生存率, objectType=article, longId=116969, objectId=a29c11696991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a29c11696991, replyNumber=0, likeNumber=0, createdTime=2017-10-22, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a29c11696991, moduleTitle=Chest：患COPD肺移植候选人的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a29c11696991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256601, encodeId=88cd125660119, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Nature：50年来超重磅进展！这种5年生存率几乎为0的脑癌将有望被治愈 | 科学大发现, objectType=article, longId=115890, objectId=819a1158909a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=819a1158909a, replyNumber=0, likeNumber=51, createdTime=2017-10-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=819a1158909a, moduleTitle=Nature：50年来超重磅进展！这种5年生存率几乎为0的脑癌将有望被治愈 | 科学大发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=819a1158909a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256600, encodeId=823c12566009f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=【CSCO 2017】陆舜教授：Nivolumab长期生存汇总数据首次亮相—3年生存率远超化疗, objectType=article, longId=115048, objectId=446f1150485b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=446f1150485b, replyNumber=0, likeNumber=74, createdTime=2017-10-03, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=446f1150485b, moduleTitle=【CSCO 2017】陆舜教授：Nivolumab长期生存汇总数据首次亮相—3年生存率远超化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=446f1150485b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256599, encodeId=08a8125659909, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Urol：对于高风险的肾细胞癌肾切除术后舒尼替尼辅助的亚组分析和全新的总生存率结果。, objectType=article, longId=114604, objectId=1f931146049e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f931146049e, replyNumber=0, likeNumber=74, createdTime=2017-09-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f931146049e, moduleTitle=Eur Urol：对于高风险的肾细胞癌肾切除术后舒尼替尼辅助的亚组分析和全新的总生存率结果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f931146049e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256598, encodeId=f8e81256598bc, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=临床试验表明：免疫治疗可以提高肺癌患者的生存率, objectType=article, longId=114178, objectId=ac671141e83d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac671141e83d, replyNumber=0, likeNumber=64, createdTime=2017-09-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac671141e83d, moduleTitle=临床试验表明：免疫治疗可以提高肺癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac671141e83d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256597, encodeId=63fd125659e2f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ANN RHEUM DIS：成人和儿童系统性红斑狼疮患者的生存率, objectType=article, longId=113468, objectId=ace11134686e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ace11134686e, replyNumber=0, likeNumber=65, createdTime=2017-09-22, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ace11134686e, moduleTitle=ANN RHEUM DIS：成人和儿童系统性红斑狼疮患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ace11134686e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256596, encodeId=f6b312565966f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Heart J：肥厚性心肌病女性患者的生存率更差, objectType=article, longId=112461, objectId=d735112461ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d735112461ef, replyNumber=0, likeNumber=74, createdTime=2017-09-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d735112461ef, moduleTitle=Eur Heart J：肥厚性心肌病女性患者的生存率更差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d735112461ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256595, encodeId=4cd11256595dd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JACC：再次手术与肺静脉狭窄患儿的生存率改善相关, objectType=article, longId=112029, objectId=9a6e1120296e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a6e1120296e, replyNumber=0, likeNumber=98, createdTime=2017-09-07, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a6e1120296e, moduleTitle=JACC：再次手术与肺静脉狭窄患儿的生存率改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a6e1120296e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256594, encodeId=517c1256594a3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=【ESC 2017】DETO2X-AMI 氧疗并不会改善心脏病症状患者的生存率, objectType=article, longId=111243, objectId=d3df11124313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3df11124313, replyNumber=0, likeNumber=41, createdTime=2017-08-31, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3df11124313, moduleTitle=【ESC 2017】DETO2X-AMI 氧疗并不会改善心脏病症状患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3df11124313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256593, encodeId=c19d1256593cd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Hepatology：肝细胞癌的放射栓塞：在应答患者中可提高生存率, objectType=article, longId=110998, objectId=4f1811099824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f1811099824, replyNumber=0, likeNumber=40, createdTime=2017-08-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f1811099824, moduleTitle=Hepatology：肝细胞癌的放射栓塞：在应答患者中可提高生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f1811099824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256592, encodeId=49271256592ce, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=SCI REP：卵巢癌患者辅助化疗起始时间与生存率之间的关系！, objectType=article, longId=110918, objectId=980311091843, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=980311091843, replyNumber=0, likeNumber=59, createdTime=2017-08-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=980311091843, moduleTitle=SCI REP：卵巢癌患者辅助化疗起始时间与生存率之间的关系！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=980311091843)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256591, encodeId=33c5125659189, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Int J Cancer:我国学者Meta分析称，他汀或可提高癌症患者生存率，确诊后应用似更有益, objectType=article, longId=110410, objectId=e0ba1104103b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0ba1104103b, replyNumber=0, likeNumber=76, createdTime=2017-08-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0ba1104103b, moduleTitle=Int J Cancer:我国学者Meta分析称，他汀或可提高癌症患者生存率，确诊后应用似更有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0ba1104103b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256590, encodeId=53371256590a4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Clin Oncol：局部前列腺癌中，无转移生存率可以替代总生存率, objectType=article, longId=109231, objectId=f70110923185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f70110923185, replyNumber=0, likeNumber=56, createdTime=2017-08-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f70110923185, moduleTitle=J Clin Oncol：局部前列腺癌中，无转移生存率可以替代总生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f70110923185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256589, encodeId=72b51256589bf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Chest：肺叶切除术的时机对临床ⅠA期肺鳞状细胞癌生存率的影响, objectType=article, longId=108757, objectId=c67a108e575c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c67a108e575c, replyNumber=0, likeNumber=60, createdTime=2017-08-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c67a108e575c, moduleTitle=Chest：肺叶切除术的时机对临床ⅠA期肺鳞状细胞癌生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c67a108e575c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256588, encodeId=fd721256588f2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：无转移生存率是局限性前列腺癌总生存率的有力替代物, objectType=article, longId=108536, objectId=1b5b108536c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b5b108536c3, replyNumber=0, likeNumber=68, createdTime=2017-08-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b5b108536c3, moduleTitle=JCO：无转移生存率是局限性前列腺癌总生存率的有力替代物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b5b108536c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256587, encodeId=fc5e125658e02, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ANN RHEUM DIS：系统性红斑狼疮成人和儿童的生存率, objectType=article, longId=108518, objectId=2152108518ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2152108518ba, replyNumber=0, likeNumber=64, createdTime=2017-08-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2152108518ba, moduleTitle=ANN RHEUM DIS：系统性红斑狼疮成人和儿童的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2152108518ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256586, encodeId=224e125658672, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Invest New Drugs.：贝伐单抗联合吉西他滨+奥沙利铂能够改善晚期胆道癌的生存率。, objectType=article, longId=107623, objectId=b4b610e62312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4b610e62312, replyNumber=0, likeNumber=61, createdTime=2017-08-05, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4b610e62312, moduleTitle=Invest New Drugs.：贝伐单抗联合吉西他滨+奥沙利铂能够改善晚期胆道癌的生存率。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4b610e62312)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Cardiovasc Ther：华法林对曲前列尼尔治疗的肺动脉高压患者生存率有影响吗？

2017-10-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Obstet Gynecol：卵巢静脉血栓患者复发性静脉血栓栓塞的发生率和生存率如何？

2017-10-24

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：经导管主动脉瓣植入后的相对生存率

2017-10-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Chest：患COPD肺移植候选人的生存率

2017-10-22

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Nature：50年来超重磅进展！这种5年生存率几乎为0的脑癌将有望被治愈 | 科学大发现

2017-10-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

【CSCO 2017】陆舜教授：Nivolumab长期生存汇总数据首次亮相—3年生存率远超化疗

2017-10-03

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Urol：对于高风险的肾细胞癌肾切除术后舒尼替尼辅助的亚组分析和全新的总生存率结果。

2017-09-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

临床试验表明：免疫治疗可以提高肺癌患者的生存率

2017-09-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ANN RHEUM DIS：成人和儿童系统性红斑狼疮患者的生存率

2017-09-22

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Heart J：肥厚性心肌病女性患者的生存率更差

2017-09-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JACC：再次手术与肺静脉狭窄患儿的生存率改善相关

2017-09-07

智智灵药 (审核中...)

前往app查看评论内容

#生存率#

【ESC 2017】DETO2X-AMI 氧疗并不会改善心脏病症状患者的生存率

2017-08-31

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Hepatology：肝细胞癌的放射栓塞：在应答患者中可提高生存率

2017-08-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

SCI REP：卵巢癌患者辅助化疗起始时间与生存率之间的关系！

2017-08-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Int J Cancer:我国学者Meta分析称，他汀或可提高癌症患者生存率，确诊后应用似更有益

2017-08-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Clin Oncol：局部前列腺癌中，无转移生存率可以替代总生存率

2017-08-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Chest：肺叶切除术的时机对临床ⅠA期肺鳞状细胞癌生存率的影响

2017-08-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：无转移生存率是局限性前列腺癌总生存率的有力替代物

2017-08-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ANN RHEUM DIS：系统性红斑狼疮成人和儿童的生存率

2017-08-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Invest New Drugs.：贝伐单抗联合吉西他滨+奥沙利铂能够改善晚期胆道癌的生存率。

2017-08-05

科室
- - 订阅+
  - 更多科室
工具
服务